… Erlotinib with concurrent carboplatin and paclitaxel did not confer a survival advantage over
carboplatin and paclitaxel … Never smokers treated with erlotinib and chemotherapy seemed …

… Conclusions: Erlotinib combined with carboplatin and paclitaxel chemotherapy did not confer
a survival advantage over carboplatin and paclitaxel alone in pts with previously untreated …

… of erlotinib in combination with other chemotherapeutic … mg erlotinib + paclitaxel/carboplatin
and a DLT of grade 3 rash was seen in 2 patients administered 150 mg erlotinib + paclitaxel/…

… Results: Enhanced sensitivity to erlotinib was observed in the doxorubicin-resistant human
breast cancer cell line MCF-7, paclitaxel-resistant human ovarian carcinoma cell line A2780, …

… No survival benefit or improvement in response rate versus chemotherapy … of erlotinib and
paclitaxel were, however, apparent in this study. Patients received 200 mg/m 2 of paclitaxel …

… chemotherapy will be randomized to receive either erlotinib … based chemotherapy will be
randomized to receive erlotinib, … Inc.) chemotherapy. The primary end point is overall survival. …

… erlotinib plus paclitaxel based chemotherapy versus paclitaxel based chemotherapy alone
[16]… In this meta-analysis, continuous erlotinib plus chemotherapy versus chemotherapy alone …

… In another randomized phase II study, a 7-day EGFR TKI–free period was scheduled before
each subsequent cycle of carboplatin/paclitaxel chemotherapy in patients with chemotherapy…

… erlotinib was similar to that with various chemotherapeutic … -fluorouracil 31 and 7.3 months
with paclitaxel plus cisplatin). … using erlotinib in combination with docetaxel, paclitaxel plus …

… to chemotherapy plus erlotinib (n=226) or chemotherapy … with chemotherapy plus erlotinib
versus chemotherapy plus … in the chemotherapy plus erlotinib and chemotherapy plus placebo …